1/2

FIEO Registered Export Ready

Glimepiride & Metformin Prolonged release Tablets IP

Name: Glimepiride & Metformin Prolonged release Tablets IP
SKU: 8520225
Availability: InStoreOnly

Sold by IndiGlobal Exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for IndiGlobal Exports.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

IndiGlobal Exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

$50,000 - $250,000

Incorporation Type

On request

Certifications & Awards

IEC Certificate GST Certificate UDYAM Registration Certificate Certificate course in International trade-from FIEO FASSAI License Drug License

Product details

What are the specifications of this product?

Overview

Glimepiride & Metformin Prolonged release Tablets IP is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of diabetes conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Diabetes Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Glimepiride & Metformin Prolonged release Tablets IP is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by IndiGlobal Exports.

Specifications

Category	Diabetes Treatment
Dosage Form	Prolonged Release Tablet
Active Ingredients	Glimepiride, Metformin
Shelf Life	As per regulatory standards (typically 24-36 months)
Packaging Type	Blister or strip packs - export grade
Pharmacopoeia Compliance	Indian Pharmacopoeia (IP) standards
Manufacturing Compliance	WHO-GMP certified facilities
Intended Use	Clinical treatment and management of diabetes mellitus
Export Readiness	Formulated and packaged per international export norms

Use cases

Category	Pharmaceuticals > Diabetes Care > Oral Antidiabetic Medications > Combination Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Glimepiride & Metformin Prolonged release Tablets IP. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does the prolonged release formulation of Glimepiride & Metformin benefit diabetic patients?

A: The prolonged release formulation provides a steady release of Glimepiride and Metformin over time, enhancing glycemic control, reducing dosing frequency, and minimizing side effects compared to immediate-release forms.

Q: Is this tablet formulation compliant with international regulatory standards for export?

A: Yes, these tablets are manufactured in WHO-GMP compliant facilities and adhere to Indian Pharmacopoeia standards, making them suitable for export to regulated and semi-regulated international markets.

Q: What packaging options are available for bulk export of these tablets?

A: The tablets are available in export-grade blister packs or strip packs designed to maintain product integrity and facilitate safe transportation during bulk export.

Q: Can these tablets be used in hospital and retail pharmacy settings?

A: Yes, due to their compliance with strict quality and safety standards, these tablets are ideal for both hospital prescriptions and retail pharmacy distributions.

Q: What shelf life can buyers expect for this product?

A: The shelf life is as per regulatory guidelines, usually ranging between 24 to 36 months, ensuring stability and efficacy throughout the storage period.

Question not answered? Ask sellers directly — typical response within 4 hours.